FluGen Inc

Showcase Sponsor

FluGen is a clinical stage vaccine company working to solve the urgent need for a more effective influenza vaccine with broader coverage and longer duration of action.  The mechanism of its M2SR, single replication, intranasal flu vaccine mimics wildtype infection generating a robust and unique immune signature.  Clinical studies to test M2SR’s ability to protect against substantially drifted strains are underway.

Sign Up for Event Updates

Get Involved At World Vaccine Congress Washington


To Sponsor Or Exhibit

Marc Rhys-Evans
+44 20 7827 5945




To Register

Tayyab Abbasi
+44 20 7092 1210




Press Relations

Karina Kusova
+44 20 7092 1071